High burden of germline variants of uncertain significance in advanced renal cell carcinoma: insights from an Indian cohort 5 de noviembre de 2026
The evidence base of Clinical Practice Guidelines for cancer in China, the Hong Kong SAR and Taiwan 3 de noviembre de 2026
Validation of the Spanish version of the shame and sigma scale for head and neck cancer survivors 3 de noviembre de 2026